IL1R2 and neoplasm: In contrast, Msh2loxP/loxP tumors showed activation of the MAPK pathway, specially upregulation of IL1r2. IL1R2 is a decoy receptor that neutralizes IL1 and is described to be upregulated in tumor-infiltrating regulatory T cells [45].